secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ribbon Acquisition Corp. (RIBB)
CIK:        0002035016
Form:       8-K
Filed at:   2025-07-01T23:59:59+00:00
Accession:  0001213900-25-060364
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ribbon Acquisition Corp. to combine with DRC Medicine in $350M equity value SPAC merger
--------------------------------------------------------------------------------

- DRC Medicine designs AI-powered allergy and infection diagnostic kits and protective face masks.
- Equity value set at $350M; consideration determined by dividing $350M by redemption price per share.
- Post-closing board: Sponsor appoints 1 director, DRC appoints 4 directors (3 independent).
- Lock-up of 6 months from closing for certain shareholders and Sponsor.
- Closing requires SPAC shareholder approval, SEC registration statement effectiveness, and Nasdaq listing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2035016/000121390025060364/0001213900-25-060364-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2035016/000121390025060364/ea0247714-8k425_ribbon.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-060364

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer